Annual SGA
$5.55 M
-$486.00 K-8.05%
December 31, 2023
Summary
- As of February 7, 2025, TTNP annual SGA is $5.55 million, with the most recent change of -$486.00 thousand (-8.05%) on December 31, 2023.
- During the last 3 years, TTNP annual SGA has fallen by -$253.00 thousand (-4.36%).
- TTNP annual SGA is now -41.60% below its all-time high of $9.50 million, reached on December 31, 1995.
Performance
TTNP SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$754.00 K
-$1.32 M-63.65%
September 30, 2024
Summary
- As of February 7, 2025, TTNP quarterly SGA is $754.00 thousand, with the most recent change of -$1.32 million (-63.65%) on September 30, 2024.
- Over the past year, TTNP quarterly SGA has dropped by -$690.00 thousand (-47.78%).
- TTNP quarterly SGA is now -90.46% below its all-time high of $7.90 million, reached on December 31, 1996.
Performance
TTNP Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.58 B
-$5.89 M-0.38%
September 30, 2024
Summary
- As of February 7, 2025, TTNP TTM SGA is -$1.58 billion, with the most recent change of -$5.89 million (-0.38%) on September 30, 2024.
- Over the past year, TTNP TTM SGA has dropped by -$1.58 billion (-28496.70%).
- TTNP TTM SGA is now -4949.52% below its all-time high of -$31.20 million.
Performance
TTNP TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TTNP Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -8.1% | -47.8% | -10000.0% |
3 y3 years | -4.4% | -43.0% | -10000.0% |
5 y5 years | -19.2% | -43.2% | -10000.0% |
TTNP Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -8.1% | +11.2% | -63.6% | at low | -5.7% | at low |
5 y | 5-year | -8.1% | +11.2% | -63.6% | +119.2% | -14.7% | at low |
alltime | all time | -41.6% | +98.1% | -90.5% | +119.2% | -4949.5% | at low |
Titan Pharmaceuticals Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $754.00 K(-63.6%) | $5.33 M(-14.3%) |
Jun 2024 | - | $2.07 M(+95.1%) | $6.22 M(+15.7%) |
Mar 2024 | - | $1.06 M(-26.4%) | $5.38 M(-3.1%) |
Dec 2023 | $5.55 M(-8.1%) | $1.44 M(-12.0%) | $5.55 M(+2.9%) |
Sep 2023 | - | $1.64 M(+33.5%) | $5.39 M(-3.0%) |
Jun 2023 | - | $1.23 M(-0.4%) | $5.56 M(-6.5%) |
Mar 2023 | - | $1.23 M(-4.3%) | $5.95 M(-1.5%) |
Dec 2022 | $6.03 M(+20.9%) | $1.29 M(-28.6%) | $6.04 M(-5.6%) |
Sep 2022 | - | $1.81 M(+11.6%) | $6.39 M(+14.9%) |
Jun 2022 | - | $1.62 M(+22.4%) | $5.57 M(+11.7%) |
Mar 2022 | - | $1.32 M(-19.8%) | $4.98 M(-0.1%) |
Dec 2021 | $4.99 M(-14.0%) | $1.65 M(+68.3%) | $4.99 M(-2.0%) |
Sep 2021 | - | $979.00 K(-5.4%) | $5.09 M(-6.4%) |
Jun 2021 | - | $1.03 M(-22.0%) | $5.44 M(-3.3%) |
Mar 2021 | - | $1.33 M(-24.1%) | $5.63 M(+0.7%) |
Dec 2020 | $5.80 M(+7.4%) | $1.75 M(+31.8%) | $5.59 M(-5920.8%) |
Sep 2020 | - | $1.33 M(+8.5%) | -$96.00 K(-106.0%) |
Jun 2020 | - | $1.22 M(-5.1%) | $1.60 M(-55.7%) |
Mar 2020 | - | $1.29 M(-132.8%) | $3.61 M(-33.2%) |
Dec 2019 | $5.40 M(-21.3%) | -$3.94 M(-230.2%) | $5.40 M(-53.8%) |
Sep 2019 | - | $3.02 M(-6.4%) | $11.69 M(+14.8%) |
Jun 2019 | - | $3.23 M(+4.8%) | $10.19 M(+22.2%) |
Mar 2019 | - | $3.08 M(+30.7%) | $8.33 M(+21.4%) |
Dec 2018 | $6.87 M(+35.5%) | $2.36 M(+55.7%) | $6.87 M(+21.9%) |
Sep 2018 | - | $1.51 M(+9.7%) | $5.63 M(+2.1%) |
Jun 2018 | - | $1.38 M(-14.6%) | $5.52 M(+3.4%) |
Mar 2018 | - | $1.61 M(+43.6%) | $5.33 M(+5.2%) |
Dec 2017 | $5.07 M(+10.3%) | $1.13 M(-19.4%) | $5.07 M(-1.4%) |
Sep 2017 | - | $1.40 M(+16.6%) | $5.14 M(+7.2%) |
Jun 2017 | - | $1.20 M(-11.4%) | $4.80 M(-0.4%) |
Mar 2017 | - | $1.35 M(+12.7%) | $4.82 M(+4.8%) |
Dec 2016 | $4.60 M(+22.4%) | $1.20 M(+14.0%) | $4.60 M(+1.9%) |
Sep 2016 | - | $1.05 M(-13.3%) | $4.51 M(+6.1%) |
Jun 2016 | - | $1.21 M(+7.3%) | $4.25 M(+12.2%) |
Mar 2016 | - | $1.13 M(+1.4%) | $3.79 M(+1.0%) |
Dec 2015 | $3.75 M(+23.3%) | $1.11 M(+40.8%) | $3.75 M(+17.0%) |
Sep 2015 | - | $792.00 K(+5.2%) | $3.21 M(-2.3%) |
Jun 2015 | - | $753.00 K(-31.2%) | $3.29 M(+1.2%) |
Mar 2015 | - | $1.09 M(+92.1%) | $3.25 M(+6.5%) |
Dec 2014 | $3.05 M(-0.6%) | $570.00 K(-34.3%) | $3.05 M(-1.7%) |
Sep 2014 | - | $867.00 K(+21.6%) | $3.10 M(+7.6%) |
Jun 2014 | - | $713.00 K(-20.4%) | $2.88 M(+0.4%) |
Mar 2014 | - | $896.00 K(+43.6%) | $2.87 M(-6.4%) |
Dec 2013 | $3.06 M(-37.2%) | $624.00 K(-3.6%) | $3.06 M(-14.1%) |
Sep 2013 | - | $647.00 K(-7.7%) | $3.57 M(-6.4%) |
Jun 2013 | - | $701.00 K(-35.7%) | $3.81 M(-10.0%) |
Mar 2013 | - | $1.09 M(-3.2%) | $4.23 M(-13.2%) |
Dec 2012 | $4.88 M(+44.8%) | $1.13 M(+26.6%) | $4.88 M(+5.2%) |
Sep 2012 | - | $890.00 K(-21.0%) | $4.64 M(+3.4%) |
Jun 2012 | - | $1.13 M(-35.0%) | $4.49 M(+4.1%) |
Mar 2012 | - | $1.73 M(+95.2%) | $4.31 M(+27.9%) |
Dec 2011 | $3.37 M(+3.2%) | $888.00 K(+20.2%) | $3.37 M(+8.5%) |
Sep 2011 | - | $739.00 K(-22.0%) | $3.10 M(+1.6%) |
Jun 2011 | - | $948.00 K(+19.5%) | $3.06 M(-2.1%) |
Mar 2011 | - | $793.00 K(+26.9%) | $3.12 M(-4.4%) |
Dec 2010 | $3.26 M | $625.00 K(-9.6%) | $3.26 M(-2.7%) |
Sep 2010 | - | $691.00 K(-31.7%) | $3.35 M(-5.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2010 | - | $1.01 M(+8.2%) | $3.54 M(-9.7%) |
Mar 2010 | - | $935.00 K(+30.8%) | $3.92 M(+14.0%) |
Dec 2009 | $3.44 M(-44.7%) | $715.00 K(-18.4%) | $3.44 M(+26.3%) |
Sep 2009 | - | $876.00 K(-37.1%) | $2.72 M(-25.9%) |
Jun 2009 | - | $1.39 M(+206.8%) | $3.67 M(-31.0%) |
Mar 2009 | - | $454.00 K(-75.2%) | $5.33 M(-40.8%) |
Sep 2008 | - | $1.83 M(-39.9%) | $9.00 M(+4.2%) |
Jun 2008 | - | $3.04 M(+37.4%) | $8.64 M(+23.9%) |
Mar 2008 | - | $2.21 M(+15.5%) | $6.97 M(+12.2%) |
Dec 2007 | $6.21 M(+27.9%) | $1.92 M(+30.7%) | $6.21 M(+13.0%) |
Sep 2007 | - | $1.47 M(+6.6%) | $5.50 M(+3.4%) |
Jun 2007 | - | $1.38 M(-5.3%) | $5.32 M(+2.7%) |
Mar 2007 | - | $1.45 M(+20.9%) | $5.18 M(+6.6%) |
Dec 2006 | $4.86 M(-9.5%) | $1.20 M(-6.6%) | $4.86 M(-0.6%) |
Sep 2006 | - | $1.29 M(+4.0%) | $4.89 M(-4.9%) |
Jun 2006 | - | $1.24 M(+9.2%) | $5.14 M(-1.9%) |
Mar 2006 | - | $1.13 M(-8.0%) | $5.24 M(-2.4%) |
Dec 2005 | $5.37 M(+2.5%) | $1.23 M(-20.0%) | $5.37 M(-2.8%) |
Sep 2005 | - | $1.54 M(+15.0%) | $5.52 M(+3.2%) |
Jun 2005 | - | $1.34 M(+6.0%) | $5.35 M(+4.3%) |
Mar 2005 | - | $1.26 M(-8.8%) | $5.13 M(-2.0%) |
Dec 2004 | $5.24 M(+2.5%) | $1.38 M(+1.2%) | $5.24 M(+3.0%) |
Sep 2004 | - | $1.37 M(+22.3%) | $5.08 M(+2.6%) |
Jun 2004 | - | $1.12 M(-18.3%) | $4.96 M(-2.7%) |
Mar 2004 | - | $1.37 M(+11.1%) | $5.09 M(-0.3%) |
Dec 2003 | $5.11 M(+0.7%) | $1.23 M(-0.6%) | $5.11 M(+1.4%) |
Sep 2003 | - | $1.24 M(-1.4%) | $5.04 M(-1.5%) |
Jun 2003 | - | $1.26 M(-9.0%) | $5.11 M(-2.6%) |
Mar 2003 | - | $1.38 M(+19.0%) | $5.25 M(+3.4%) |
Dec 2002 | $5.08 M(-5.7%) | $1.16 M(-11.6%) | $5.08 M(-2.2%) |
Sep 2002 | - | $1.31 M(-5.5%) | $5.19 M(+0.0%) |
Jun 2002 | - | $1.39 M(+15.0%) | $5.19 M(+3.6%) |
Mar 2002 | - | $1.21 M(-5.2%) | $5.01 M(-6.9%) |
Dec 2001 | $5.38 M(+32.3%) | $1.28 M(-2.7%) | $5.38 M(+0.3%) |
Sep 2001 | - | $1.31 M(+8.3%) | $5.37 M(+1.2%) |
Jun 2001 | - | $1.21 M(-23.5%) | $5.30 M(+10.6%) |
Mar 2001 | - | $1.58 M(+25.5%) | $4.80 M(+17.9%) |
Dec 2000 | $4.07 M(+45.4%) | $1.26 M(+1.2%) | $4.07 M(+19.4%) |
Sep 2000 | - | $1.25 M(+77.1%) | $3.41 M(+15.1%) |
Jun 2000 | - | $704.00 K(-17.9%) | $2.96 M(+7.4%) |
Mar 2000 | - | $857.00 K(+42.8%) | $2.76 M(+2.1%) |
Dec 1999 | $2.80 M(-24.3%) | $600.00 K(-25.0%) | $2.70 M(-10.0%) |
Sep 1999 | - | $800.00 K(+60.0%) | $3.00 M(0.0%) |
Jun 1999 | - | $500.00 K(-37.5%) | $3.00 M(-14.3%) |
Mar 1999 | - | $800.00 K(-11.1%) | $3.50 M(-5.4%) |
Dec 1998 | $3.70 M(-43.1%) | $900.00 K(+12.5%) | $3.70 M(-22.9%) |
Sep 1998 | - | $800.00 K(-20.0%) | $4.80 M(-12.7%) |
Jun 1998 | - | $1.00 M(0.0%) | $5.50 M(-9.8%) |
Mar 1998 | - | $1.00 M(-50.0%) | $6.10 M(-4.7%) |
Dec 1997 | $6.50 M(+22.6%) | $2.00 M(+33.3%) | $6.40 M(-48.0%) |
Sep 1997 | - | $1.50 M(-6.3%) | $12.30 M(+5.1%) |
Jun 1997 | - | $1.60 M(+23.1%) | $11.70 M(+4.5%) |
Mar 1997 | - | $1.30 M(-83.5%) | $11.20 M(+3.7%) |
Dec 1996 | $5.30 M(-44.2%) | $7.90 M(+777.8%) | $10.80 M(+272.4%) |
Sep 1996 | - | $900.00 K(-18.2%) | $2.90 M(+45.0%) |
Jun 1996 | - | $1.10 M(+22.2%) | $2.00 M(+122.2%) |
Mar 1996 | - | $900.00 K | $900.00 K |
Dec 1995 | $9.50 M | - | - |
FAQ
- What is Titan Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual SGA year-on-year change?
- What is Titan Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly SGA year-on-year change?
- What is Titan Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals TTM SGA year-on-year change?
What is Titan Pharmaceuticals annual SGA?
The current annual SGA of TTNP is $5.55 M
What is the all time high annual SGA for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual SGA is $9.50 M
What is Titan Pharmaceuticals annual SGA year-on-year change?
Over the past year, TTNP annual SGA has changed by -$486.00 K (-8.05%)
What is Titan Pharmaceuticals quarterly SGA?
The current quarterly SGA of TTNP is $754.00 K
What is the all time high quarterly SGA for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly SGA is $7.90 M
What is Titan Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, TTNP quarterly SGA has changed by -$690.00 K (-47.78%)
What is Titan Pharmaceuticals TTM SGA?
The current TTM SGA of TTNP is -$1.58 B
What is the all time high TTM SGA for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM SGA is -$31.20 M
What is Titan Pharmaceuticals TTM SGA year-on-year change?
Over the past year, TTNP TTM SGA has changed by -$1.58 B (-28496.70%)